Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC18H17NO3 |
InChIKeyRFWCIJWQGHFULK-UHFFFAOYSA-N |
CAS Registry503468-03-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | GB | 27 Jan 2005 |